CID 16227496

N-[2-(1h-1,3-benzodiazol-2-yl)-1-(furan-2-yl)ethylidene]hydroxylamine

Structural Information

Molecular Formula
C13H11N3O2
SMILES
C1=CC=C2C(=C1)NC(=N2)C/C(=N/O)/C3=CC=CO3
InChI
InChI=1S/C13H11N3O2/c17-16-11(12-6-3-7-18-12)8-13-14-9-4-1-2-5-10(9)15-13/h1-7,17H,8H2,(H,14,15)/b16-11-
InChIKey
FHEQCGZTZCRMLB-WJDWOHSUSA-N
Compound name
(NZ)-N-[2-(1H-benzimidazol-2-yl)-1-(furan-2-yl)ethylidene]hydroxylamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

241.08513 Da
Monoisotopic Mass

2.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 242.09241 151.7
[M+Na]+ 264.07435 163.9
[M+NH4]+ 259.11895 159.0
[M+K]+ 280.04829 162.0
[M-H]- 240.07785 155.3
[M+Na-2H]- 262.05980 158.3
[M]+ 241.08458 154.2
[M]- 241.08568 154.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.